BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 78 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,012 | +7.4% | 25,955 | +22.4% | 0.00% | – |
| Q2 2023 | $348,268 | +2.1% | 21,210 | +3.9% | 0.00% | – |
| Q1 2023 | $341,135 | +23.3% | 20,415 | +13.9% | 0.00% | – |
| Q4 2022 | $276,660 | +558.7% | 17,930 | +530.7% | 0.00% | – |
| Q3 2022 | $42,000 | +13.5% | 2,843 | +23.6% | 0.00% | – |
| Q2 2022 | $37,000 | -33.9% | 2,300 | -17.9% | 0.00% | – |
| Q1 2022 | $56,000 | -31.7% | 2,800 | -13.0% | 0.00% | – |
| Q4 2021 | $82,000 | +141.2% | 3,220 | +147.7% | 0.00% | – |
| Q3 2021 | $34,000 | -10.5% | 1,300 | 0.0% | 0.00% | – |
| Q2 2021 | $38,000 | +11.8% | 1,300 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | +183.3% | 1,300 | +225.0% | 0.00% | – |
| Q4 2020 | $12,000 | +20.0% | 400 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | +25.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -96.4% | 400 | -96.8% | 0.00% | – |
| Q1 2020 | $224,000 | – | 12,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
| Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
| Matisse Capital | 250,000 | $6,574,000 | 0.95% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
| 1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
| Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
| Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
| Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |